User:Kellie Toohey/Meetings and Communication

Meetings are held weekly with my primary supervisor to discuss the learning outcomes and progress of the portfolio. I have documented some key meetings with external supervisors and collaborators on the project below.

* Meeting TCH 5th August 2013 Dr Paul Craft, Proff Leonard Arnolda, Dr Julie Cooke, Kellie Toohey PhD Candidate

Meeting notes;


 * Ethics approval – Kellie to apply at UC and send through to Proff and Paul for ACT Health ethics approval
 * Proff will email research proposal to his people
 * Paul Craft agreed to be an advisor for pilot study and main study
 * Kellie to develop consent form and sent through to Paul
 * Data base will be discussed further as it can form part of the PhD project – Date to be set – Data base includes 2500 women who have been through breast cancer treatment over the past 10 years and have given consent to use their data for research

* Meeting TCH 16th September 2013 Leonard Arnolda, Paul Craft, Kellie Toohey

Meeting notes;

* Contraindications to exercise:
 * Ethics approval required for TCH – pilot study and data base project – Kellie will start both on the NEAF – lets aim for 2 weeks to get this in?
 * Pilot study UC ethics application has been submitted
 * Pilot study to start Feb 2014
 * Main study starting May 2014 – intervention complete by August 2014
 * Database study and literature review by December 2013
 * Database – Paul to provide a report with what information is retrievable and advice on interest;
 * Physical activity recall – pre-diagnosis, during treatment, 1 and 5 years post diagnosis
 * Need to refine group to target – need your advice
 * Current trials in the US – Paul to provide information
 * Kellie to contact – ACT Breast cancer treatment group with information on the study
 * Kellie to meet and discuss study with Paul’s team – need to make a time
 * ABC radio interview – Kellie this Sunday to introduce PhD and project
 * Hematologic guidelines for cancer patients:
 * Platelets <50,000
 * WBC <3000
 * Haemoglobin < 10 g.dL
 * Precautions requiring modification and/or physician approval:
 * Platelets >50,000-150,000: avoid tests that increase risk of bleeding
 * WBC >3000-4000: ensure sterilisation of equipment
 * Haemoglobin >10 – 13.5 – caution with maximal tests

NSW CSC & Canberra Hospital Clinicians Workshop Friday 18th October 2013, 11:00am - 3:00pm Canberra Hospital Conference Room

￼11:00am - 11:15am 11:15am - 12:15pm 12:15pm - 12:45pm 12:45pm - 1:45pm 1:45pm - 2:45pm 2:45pm - 3:00pm

* Paul Craft/Kellie Toohey - Cardiometabolic Disease in Breast Cancer Survivors
 * Welcome and Introduction
 * NSW CSC Presentations
 * David Goldstein - Neurotoxicity
 * Kate Webber - Survivorship Models & Endophenotypes Sarah Horsfield - Cognitive Research
 * Carolina Sandler - Fatigue & Exercise
 * Lunch Break
 * Canberra Clinicians Presentations
 * Megan Nutt/Toni Ashmore - ACT Survivorship and Psychosocial Model of Care
 * Christopher Wilder/Angela Rezo - Exercise and Aromatase Inhibitors
 * Robin-Stuart-Harris - Chemotherapy and Cognitive Impairment
 * Collaborations Brainstorming
 * Close